Atomwise
Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.
About
Atomwise leverages artificial intelligence to accelerate the discovery of novel small molecule therapeutics. Their AtomNetĀ® platform uses deep learning to predict the binding of small molecules to target proteins, significantly reducing the time and cost associated with traditional drug discovery methods. Teams look it up for Drug Discovery, Life Sciences, Healthcare.
Frequently asked
What does Atomwise do?
Atomwise is a Drug Discovery company that offers Platform. Teams look it up for Life Sciences, Healthcare, Drug Discovery AI. It is based in San Francisco, United States and was founded in 2012. Public records show about 15 people and $176M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Atomwise raised?
Atomwise has raised a total of $176M in funding. The most recent round on record is Grant.
Where is Atomwise headquartered?
Atomwise is headquartered in San Francisco, United States.
When was Atomwise founded?
Atomwise was founded in 2012.
What industry does Atomwise operate in?
Atomwise operates in Drug Discovery, Life Sciences, Healthcare, Drug Discovery AI, Biotech.
How many employees does Atomwise have?
Atomwise has approximately 15 people on record.
Strength of the siteās backlink profile, on Ahrefsā 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the companyās own site. Measured by Google, not by us.